CPhI India offers diverse programme to support the growing Indian pharma market

Cluster of India-focused events offer attendees a dedicated platform to network with key decision makers in the Indian pharmaceutical industry

Leading events organiser UBM Live has announced details of CPhI India and its co-located events, which will be hosted from 30 November – 2 December 2011 at the Bombay Exhibition Centre in Mumbai, India.

Focused on pharmaceutical ingredients, CPhI India will be co-located with: P-MEC India for pharmaceutical equipment, machinery and technology; ICSE India for contract services, clinical trials; and CRO and the BioPh trail for the biopharma market. Catering to all sectors in the pharma industry, both domestic and international, UBM Live’s cluster of India-focused events offer attendees a dedicated platform to network with key decision makers in the Indian pharmaceutical industry, connect with existing partners and make new contacts. In 2010 the events hosted more than 26,400 visitors and 800 exhibiting companies, figures that UBM Live expects to be exceeded this year.

Continuing UBM Live’s commitment to developing value-added initiatives for visitors and exhibitors, the CPhI India Conference Series will return in 2011. The programme will cover a selection of key trends and topics pertinent to the Indian and South Asian pharmaceuticals markets, including:

  • Global clinical trials
  • Global biosimilars regulations
  • Healthcare and OTC drugs
  • Developing difficult generics
  • Export potential;
  • Competitive API strategies

The conference series will feature high level speakers from respected companies such as Sanofi-Aventis, GlaxoSmithKline, Pfizer and Dr. Reddy’s Laboratories.

‘Mirroring the increasing importance of the Indian pharmaceutical market, CPhI India and co-located events have been built around a unique programme based on consultation and feedback from visitors and exhibitors,’ said Annemieke Timmers, brand director CPhI. ‘We have geared the show to deliver significant return on investment (ROI) for pharma professionals who are currently working with or looking to establish relationships with Indian pharmaceutical companies.

‘Our visitors are guaranteed to benefit from strengthening current business relations and making new business connections in a market that is well equipped to scale-up to requests for products and services quickly through networks that take advantage of the latest technologies available.’

CPhI India and P-MEC India are the largest and most comprehensive pharma industry events in South Asia and have gained a reputation as the ‘must attend’ events in this market. Additionally, ICSE India has quickly gained a positive reputation in the market by offering direct access to the outsourcing and contract services sector which is one of the fastest growing segments within the Indian pharmaceutical industry, and weekly pre-registrations are currently running 300% higher than at the same time in 2010.

Companies